⁶⁸Ga-RAYZ-8009 is safe and allows for high-contrast imaging of GPC3-positive hepatocellular cancer. https://ow.ly/vRgp50UeQSo #NuclearMedicine #MolecularImaging #HCC
The Journal of Nuclear Medicine - JNM
Book and Periodical Publishing
Reston, Virginia 10,715 followers
High-impact, peer-reviewed research in nuclear medicine, molecular imaging and radiopharmaceutical therapy.
About us
The Journal of Nuclear Medicine (JNM) is an international peer-reviewed medical imaging journal publishing high-impact research in nuclear medicine, molecular imaging and radiopharmaceutical therapy.
- Website
-
https://jnm.snmjournals.org/
External link for The Journal of Nuclear Medicine - JNM
- Industry
- Book and Periodical Publishing
- Company size
- 51-200 employees
- Headquarters
- Reston, Virginia
- Type
- Nonprofit
- Founded
- 1961
- Specialties
- Nuclear Medicine, Molecular Imaging, Radiopharmaceutical Therapy, and Theranostics
Locations
-
Primary
Get directions
Reston, Virginia 20190, US
Employees at The Journal of Nuclear Medicine - JNM
Updates
-
New SNMMI procedure standard/EANM practice guideline for fibroblast activation protein PET: https://ow.ly/zrNz50UeQOq #NuclearMedicine #PETscan
-
Illustrated Post: Should whole-body staging with ⁶⁸Ga-DOTATOC PET/CT of high-grade meningiomas become standard practice? https://ow.ly/PsGz50UeQKy #NuclearMedicine #Meningioma #MedicalImaging
-
-
Clinical ¹⁸F-AlF-RESCA-T4 immuno-PET/CT imaging can screen patients for Trop2-targeted therapies and differentiate lung inflammation from cancer. https://ow.ly/gFHq50U9Bo2 #MolecularImaging #LungCancer #PETscan
-
-
JNM Continuing Education: Precision oncology in #melanoma. https://ow.ly/vP3g50U9BmI #NuclearMedicine #MolecularImaging #RPTherapy
-
-
Check out JNM's latest podcast: "Social Media in (Nuclear) Medicine. https://ow.ly/uWWI50Uowum #NuclearMedicine #Theranostics #MedicalImaging #RPTherapy
-
-
A real-world comparison of cabazitaxel versus ¹⁷⁷Lu-PSMA radiopharmaceutical therapy in metastatic castration-resistant prostate cancer: https://ow.ly/TP2G50U9BjT #NuclearMedicine #RPTherapy #ProstateCancer
-
-
Among PET-based VISION-eligible patients, TheraP-I patients had shorter PSA-PSA and OS, which was mainly driven by discordant findings between PSMA PET and ¹⁸F-FDG PET. https://ow.ly/v3QU50U9Bhl #NuclearMedicine #ProstateCancer
-
-
CD70-targeted immuno-PET/CT imaging is a precise and superior method for evaluating tumor burden and suspected metastases in clear cell renal cell carcinoma patients. https://ow.ly/mB3m50U6mhU #MolecularImaging #ccRCC #PETscan
-
-
What’s the feasibility of ¹⁷⁷Lu-PSMA administration as an outpatient procedure for #ProstateCancer? https://ow.ly/KEXM50U6mcq #NuclearMedicine #RPTherapy